2015-2016 Seminars

September 30, 2015. Nanjoo Suh, Ph.D., Professor, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University. “Targeting breast cancer stem cells as novel cancer prevention approaches.”

November 4, 2015. Mirit Aladjem, Ph.D., Senior Investigator, Head, DNA Replication Group, Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH. “The Flexible DNA replication landscape facilitating genomic Stability.”

November 6, 2015. Selina Chen-Kiang, Ph.D, Professor of Pathology, Professor of Immunobiology and Microbial Pathogenesis, Mayer Cancer Center at Weill Cornell Medical College. “Targeting CKD4/6 in Human Cancer: Mechanism and Therapies.”

December 2, 2015. Lance A Liotta, Ph.D., University Professor, Co-Director for Applied Proteomics and Molecular Medicine, Medical Director Clinical Proteomics Lab. George Mason University. “ Proteomics for individual therapy of cancer.”

January 20, 2016. Gerd Blobel, M.D., Ph.D. Frank E. Weise III Professor of Pediatrics, The children’s Hospital of Philadelphia, Co-Director U-Penn Epigenetics Program, Perelman School of Medicine, University of Penn. “Functions, mechanism and therapeutics potential of chromatin looping.”

February 24, 2016. Robert Sobol, Ph.D. Point Clear Charities Professor of Oncologic Sciences, Chief Molecular and Metabolic Oncology Program, Abraham A Mitchell Distinguished Investigator, University, USAMCI GEED Lab/ Technology Development Facility, University of South Alabama Mitchell Cancer Institute. “ Protein Complexes and Ubiqitylation regulates Base Excision Repair Protein Stability.”

March 9, 2016. Richard Eckert, Ph.D. John F.B. Weaver Distinguished Professor, Chari – Department of Biochemistry and Molecular Biology, Associate Director – Basic Sciences Greenbaum Cancer Center, University of Maryland. “A Novel Mechanism of Epidermal Cancer Stem Cell Driven Angiogenesis.”

May 11, 2016. Christopher Kemp Ph.D. Member, Human Biology Division, Member, Public Health Science Division. Fred Hutchinson Cancer Research Center, Seattle, WA. “Toward Personalized oncology Functional Testing of Patient Derived Tumor Cells to Identify Novel Drug”.